ENZON
ENZON
We are a biopharmaceutical company dedicated to the development and commercialization of therapeutics to treat patients with cancer and other life-threatening diseases. Our specialized sales force markets ABELCET?, ONCASPAR?, ADAGEN?, and DEPOCYT? in North America. In addition, we also receive royalties on sales of PEG-INTRON?, marketed by Schering-Plough Corporation, and MACUGEN?, marketed by OSI Pharmaceuticals and Pfizer Inc. Our product-driven strategy includes an extensive drug development program that leverages our proprietary technologies, including a next-generation PEGylation platform that utilizes linkers designed to release compounds at a controlled rate. Internal research and development efforts are complemented with strategic initiatives, such as partnerships designed to broaden our revenue base or provide access to promising new technologies or product development opportunities.
685 Route 202/206
Bridgewater, NJ 08807
(map)
Phone: (908)541-8600
Fax: (908)575-9457
Votes:40
Comments: 0